CarWale on MSN

MG’s new Beijing Auto Show line-up could shape its India future

MG has showcased the 2026 MG4 at the Beijing Auto Show, while also previewing the upcoming MG 4X electric SUV and the MG 07 ...
Energy Digital

MG: Advancing EV Energy with Semi-Solid-State Batteries

MG will introduce semi-solid-state batteries in Europe, aiming to improve EV efficiency, performance and cold-weather ...

Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in ...
Electrek

I went to the Beijing Auto Show and it’s a glimpse at the future of the auto industry

I just spent two days at the 2026 Beijing Auto Show (Auto China 2026), and I need to tell you something: the future of the ...
The Mail & GuardianOpinion

China’s rural vitalisation strategy is reshaping the future of global development

Having declared a victory over absolute poverty at the start of the decade, Beijing did not simply declare the mission ...

PTC Therapeutics, Inc.: PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam

Dose-dependent benefit on cUHDRS in Stage 2 participants compared to matched natural history cohort, with 52% slowing at 10 mg dose - - Continued evidence of favorable ...
The Manila Times

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026

Tokyo, Japan and Cambridge, UK, 1 May 2026 - Nxera Pharma ('the Company” or 'Nxera”; TSE: 4565) provides an update on ...
The Mail & GuardianOpinion

Unity in Struggle: ANC–SACP alliance remains central to South Africa’s political future

South Africa’s experience is not unique. Across Africa and beyond, progressive forces have historically united, often ...

THC drinks are exploding at South Florida bars, breweries and restaurants — but will they last?

There’s pineapple, strawberry, watermelon mojito and Key lime margarita flavors — all laced with the compound that gets ...

Axsome Therapeutics, Inc.: Axsome Therapeutics Announces FDA Approval of AUVELITY (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with ...

AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to Alzheimer's disease The safety and tolerability profile of ...

InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the ...
The Manila Times

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

Robust monotherapy efficacy in KRAS G12X NSCLC: 62% uORR in 2L+ and 75% uORR in post-ICI/platinum 2/3L at 16-32 mg QD PAD, and 64% uORR in 2L+ at 24-32 mg QD RDE ...